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ABSTRACT
increased  breast  tumor  growth  in  MeS  mice  modulating  multiple  genes  and  miRNA  
to  mesenchymal  transition,  mammary  development  and  cell  communication  in  the  
INTRODUCTION
Breast  cancer  is  the  leading  cause  of  cancer  death  
among  women,  after  skin  cancers  [1].  Although  genetic  
determine  most  of   the  differences   in  cancer   risk  across  
populations  and  among  individuals  [2,  3].  It  is  estimated  
that  around  30%  of  total  cancer  deaths  in  United  States  
could  be  attributed  to  life  style,  diet  and  physical  activity;;  
all  factors  associated  to  metabolic  syndrome  (MeS)  [4].
Based   on   the   National   Cholesterol   Education  
Program’s  Adult   Treatment   Panel   III   (NCEP  ATP   III)  
criteria,  MeS  is  a  cluster  of  pathophysiological  disorders  
that   comprises   at   least   three   of   the   following   factors:  
Several   studies  have  established   that  components  
of   MeS   are   positively   correlated   with   breast   cancer  
development  [6–9].  In  addition,  MeS  has  been  associated  
with  breast  cancer  risk  in  women,  and  this  correlation  is  
stronger  within  postmenopausal  population  [10–12].
Recently,  we  have  reported  that  gene  transcription  
provides  a  molecular  link  among  MeS,  CtBP1  function  
and   tumor   growth   in   prostate   cancer   [13].   CtBP1   is   a  
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such   as  BRCA1,   PERP,   PTEN,   p21CIP1/WAF1,   Bax,   Noxa  
and  E-­cadherin  [14].  CtBP1  was  proposed  as  a  metabolic  
for  NADH  compared  with  NAD+  [16].
There  are  numerous  in  vitro  studies  supporting  that  
CtBP1  regulates  multiple  genes  related  to  tumorigenesis,  
tumor  progression  and  metastasis   in  breast  cancer  cells  
[17–22].   Clinical   studies   demonstrated   that   CtBP1  
overexpression  was   observed   in   invasive   ductal   breast  
CtBP1   protein   expression   in   breast   cancer   patients   is  
associated  with  lower  median  survival  [17].  However,  the  
effect  of  CtBP1  hyperactivation  by  MeS  in  breast  cancer  
development  and  progression  remains  unexplored.
In   this   work   we   examined   the   role   of   CtBP1   in  
breast   carcinogenesis   and   tumor   growth   using   a   MeS  
experimental   model.   We   found   that   MeS   increased  
mammary   gland   development   and   induced   CtBP1  
expression  in  mammary  ducts.  MeS  was  also  associated  
population.  CtBP1  expression  induced  breast  cancer  cells  
proliferation  by  inhibiting  cell  cycle  arrest.  Importantly,  
CtBP1  increased  breast  tumor  growth  in  our  preclinical  
orthotopic  xenograft  model  regulating  the  expression  of  
mRNAs  and  miRNAs  involved  in  cell  proliferation,  cell  
communication,   progenitor   cells   phenotype,   epithelial  
to   mesenchymal   transition   (EMT)   and   mammary  
development  in  breast  cancer  tumors.
RESULTS
HFD  induced  MeS  in  female  athymic  nude  mice
To   analyze   the   involvement   of   CtBP1   in   breast  
carcinogenesis,  female  nu/nu  mice  were  chronically  fed  
with  HFD  or  CD.  Body  weight  was  measured  weekly.  
body   weight   (Figure   1A),   serum   hypercholesterolemia  
(Figure   1B)   and   hyperglycemia   (Figure   1C)   compared  
to  control  animals  with  no  differences  in  the  triglyceride  
levels   (Figure  1D).  Histopathological  analysis   revealed  
that  HFD  mice  developed  liver  diffuse  steatosis  (Figure  
alterations  (data  not  shown).
MeS  increased  postnatal  mammary  gland  
development  and  induced  CtBP1  expression  in  
mammary  ducts
Whole  mount  assay  and  histological  analysis  from  
the  number  of  branches  and  TEB  in  MFP  from  HFD  fed  
animals  (Figure  1F,  1G).  In  addition,  44%  of  mammary  
ducts   from   HFD   mice   were   covered   with   prominent  
mammary  glands  from  CD  animals  developed  this  feature.  
Interestingly,  CtBP1  and  Cyclin  D1  expression  positively  
Consistently  with  an  increase  in  mammary  gland  epithelial  
expression  levels  in  the  mammary  tissue  of  experimental  
animals  (Figure  1I).
Serum  from  mice  with  MeS  increased  the  stem-­
like/progenitor  cell  population  in  breast  cancer  
cells
cells   with   detectable   CtBP1   expression   (Figure   2A),  
were   exposed   to   medium   supplemented   with   serum  
obtained   from   HFD   (HFDS)   or   CD   fed   mice   (CDS)  
and   a   mammosphere   formation   assay   was   performed.  
We  performed  mammospheres  using  this  particular  cell  
Serum  from  mice  with  MeS  augmented  both  the  number  
In  addition,  a  secondary  mammosphere  formation  assay  
mammospheres   to   HFDS   or   CDS.   Both   sera,   CDS  
and   HFDS,   diminished   the   capability   of   the   primary  
mammospheres  to  form  secondary  ones  (Figure  2B  versus  
D).  Strikingly,  mammospheres  exposed  to  HFDS  showed  
increased  capability  to  form  secondary  spheres  compared  
to  CDS  (Figure  2D).  We  also  developed  clonogenic  assays  
HFDS   increased   colony   formation   compared   to   CDS  
(Figure   2E).   In   summary,   our   results   demonstrate   that  
HFDS  enriched  the  progenitor  population  of  breast  cancer  
cells  and  increased  their  capability  to  proliferate.
CtBP1  expression  increased  breast  cancer  cell  
proliferation  inhibiting  cell  cycle  arrest  and  
inducing  Cyclin  D1  expression
We  analyzed  CtBP1  expression  levels  in  different  
negative   breast   cancer   cells   showed   CtBP1   increased  
expression  levels  compared  to  luminals  (Figure  3A).  We  
the  highest  CtBP1  expression  levels  (Figure  3A).
Both,  CtBP1  protein  and  mRNA  levels  were  determined  
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Figure  1:  MeS  increased  postnatal  mammary  gland  development  and  induced  CtBP1  expression  in  mammary  ducts.  
Female  nu/nu  mice  (N=24)  were  chronically  fed  (16  weeks)  with  HFD  or  CD.  A.  Mice  body  weight  follow  up  during  the  experiment.  B.  
Cholesterol,  C.  Glucose,  and  D.  Triglycerides  serum  levels  determined  after  mice  euthanasia.  Histograms  show  media  and  SD  values  of  one  
E.
F.  Mammary  glands  from  mice  fed  with  HFD  or  CD  were  whole  
mounted  and  stained  with  aluminum  carmine  red  solution.  G.
H.
HFD  
Group  1:  mammary  glands  from  HFD  fed  mice  that  show  normal  ducts;;  HFD  Group  2:  mammary  glands  from  HFD  fed  mice  that  show  
I.
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shown,   shRNA   CtBP1   transfection   decreased   60%   of  
CtBP1   expression   (Figure   3B);;   while   pcDNA3  CtBP1  
transfection  induced  2  fold  CtBP1  expression  (Figure  3C).
We   assessed   proliferation   of   CtBP1   expression  
modulated  cells  growing  at  the  FBS  range  0  to  10%.  We  
(Figure   3D).   In   addition,   CtBP1   depletion   induced  
an   accumulation   of   cells   in   G1   phase   comparing   to  
controls,  when  cells  were  cultured  without  FBS  (Figure  
3E).   Furthermore,   CtBP1   depletion   (Figure   3F)   and  
induced  Cyclin  D1  expression,  compared  to  control  cells.
Altogether,  these  results  demonstrate  that  CtBP1  is  
implicated  in  cell  proliferation  since  its  depletion  induces  
cell  cycle  arrest  and   inhibits  cell  proliferation   in  breast  
cancer  cells.
CtBP1  increased  breast  tumor  growth  in  mice
We  inoculated  CtBP1  depleted  (shRNA  CtBP1)  or  
MFP  from  control  or  MeS  nu/nu  mice.  Tumor  size  was  
was  observed  in  CtBP1  depleted  xenografts  compared  to  
controls  in  both,  HFD  or  CD  fed  mice  (Figure  4A).  As  
shown   in   Figure   4B   and   4C,   the   diminution   of  CtBP1  
group.
CtBP1  and  MeS  regulated  the  expression  of  
genes  that  are  involved  in  cell  proliferation,  
progenitor  cells  phenotype,  EMT  and  mammary  
development  in  breast  tumors
Expression  of  genes  involved  in  cell  proliferation  
(Cyclin  D1),  progenitor  cell  phenotype  (Gli1,  RIP140),  
EMT  (Vimentin,  Slug,  Snail)  and  mammary  development  
(RANK,   OPG,   RIP140
from  CtBP1  depleted  or  control  xenografts  developed  in  
MeS  or  control  mice.  We  found   that  CtBP1  modulated  
expression   of   genes   which   conferred   to   tumors   a  
highly   proliferative,   dedifferentiated   and  mesenchymal  
Gli1,  RIP140,  Slug,  RANK  and  OPG  expression.  CtBP1  
Figure  2:  Serum   from  mice  with  MeS   increased   the   stem-­like/progenitor   cell  population   in  breast   cancer   cells.  A.  
B.
C.  Left   panel:
Right  panel:  mammospheres  images.  D.
secondary  mammosphere  formation  assay  was  performed.  Number  and  diameter  of  mammosphere  were  determined.  E.  Clonogenic  assay  
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Figure   3:   CtBP1   expression   increased   breast   cancer   cell   proliferation   inhibiting   cell   cycle   arrest   and   inducing  
Cyclin  D1  expression.  A.
B.
and  control  cells  by  WB  (left right
C.  CtBP1  expression  was  determined  by  
D.  Stable  
(left)  or  transient  (right
E.
Media  and  SD  values  from  two  biological  replicates  are  shown.  F-­G.
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Figure  4:  CtBP1  increased  breast  tumor  growth  in  mice  with  MeS.  A.  Tumor  growth  from  CD  or  HFD  orthotopic  xenografts  
inoculated  with  shRNA  scramble  or  shRNA  CtBP1  cell  lines.  Curves  indicate  media  and  SD  values  of  one  representative  experiment  with  
6  mice.  B. C.  CtBP1  IHC  from  tumor  
D.
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depletion  diminished  Vimentin  and  Cyclin  D1  expression.  
Interestingly,  Cyclin  D1  was  the  only  tested  target  that  was  
Altogether  these  results  suggest  that  Cyclin  D1  is  an  
important  CtBP1  target  modulated  in  the  mammary  gland  
and  in  breast  tumor  by  MeS.
CtBP1  modulated  multiple  miRNAs  involved  
in  metabolic  process,  cell  cycle  and  cell  
communication  in  breast  cancer  associated  to  
MeS
to  CtBP1  and  MeS,  GeneChip  miRNA  4.0  Affymetrix  was  
hybridized  to  total  RNA  isolated  from  CtBP1  depleted  or  
control   xenograft   tumors   generated   in  mice  with  MeS.  
Using  miRecords  data  base,  we  obtained  77  predicted  
this  set  of  42  differentially  expressed  miRNA  (Supplemental  
Table  2).  Functional  GO  analysis  of  all  these  genes  revealed  
an  enrichment  of  localization,  metabolic  processes,  cellular  
process  and  biological  regulation  categories,  among  other  
processes  within  these  GO  functions;;  we  found  important  
categories   overrepresented,   such   as   cell   cycle,   cell  
genes   using  miRTarBase.  We   found   a   complete   list   of  
Table  3).  GO  functional  analysis  displayed  enrichment  at  
metabolic  process,  cellular  process,  biological  regulation  
and   developmental   process   categories   (Supplemental  
Figure   1A).   Interestingly,   analyzing   these   top   four  
enriched   sets,   we   found   again   enrichment   of   genes  
involved  in  cell  cycle,  cell  communication  and  primary  
metabolic  processes  (Supplemental  Figure  1B).
DISCUSSION
In   this   work   we   generated   a   MeS   experimental  
mouse   model   chronically   feeding   animals   with   HFD.  
We   found   that   this   diet   increased   postnatal   mammary  
gland   development   and   proliferation   observed   by   two  
particular  features:  high  number  of  branches  and  TEB;;  and  
prominent  duct  patterns  (44%  of  mice).
Previously   it   was   reported   a   positive   association  
between  number  of  TEB  and  breast  cancer  risk  in  rodents  
[23].  It  was  suggested  that  this  is  due  to  the  presence  of  
stem  cells  in  this  undifferentiated  structure  that  support  
mammary  gland  proliferation  and  branching  [24].  Several  
studies  proposed  that  early  life  dietary  components,  such  
as  HFD,  induce  the  formation  of  TEB  and  correlates  with  
proliferation  of  ductal  tree  that  augment  mammographic  
density   is   consider   a   risk   factor   for   breast   cancer   in  
humans  [30].
In   this   work   HFD   induced   prominent   ducts  
formation  in  the  mammary  glands.  The  prominent  duct  
this  feature  with  increased  breast  cancer  risk  in  women  
[31].  More  important,  we  found  that  the  prominent  ducts  
showed  increased  expression  levels  of  CtBP1  and  Cyclin  
D1  proteins.
We  previously  found  that  CtBP1  depletion  impairs  
prostate  tumor  growth  in  mice  with  MeS  [13].  Although,  
that  report  demonstrated  that  CtBP1  is  crucial  for  prostate  
tumor  growth;;   it  was  unsuccessful   to  determine  CtBP1  
role  in  prostate  carcinogenesis.  Here,  using  breast  cancer  
cancer.  First,  MeS  induces  mammary  glands  proliferation  
triggering  breast  carcinogenesis.  Second,  CtBP1  depletion  
dramatically   decreases   breast   orthotopic   tumor   growth  
in   these   mice   independent   of   diet.   We   speculate   that  
HFD   induces   NADH   activating   CtBP1   expression   in  
the   mammary   gland   which,   in   turn,   induce   prominent  
epithelia  ducts  and   trigger  TEB  formation.  After   tumor  
growth   initiates,   high  CtBP1  expression  might   provide  
a  worse  prognosis  to  the  patients.  Future  studies  should  
be  performed   to  determine  CtBP1   role   in  breast   tumor  
progression  (See  hypothetical  model  at  Figure  6).  Hence,  
between  HFD  and  breast  carcinogenesis.
Importantly,   xenograft   gene   expression   analysis  
growth   in   mice   with   MeS   regulating   expression   of  
genes   involved   in   proliferation,   stem   cell   phenotype,  
EMT  and  breast  development.  Previous  preclinical  and  
clinical  studies  demonstrated  that  CtBP1  overexpression  
confer  a  worse  outcome  for  patients  with  breast  cancer  
associated  to  MeS.
miRNAs   function   as   master   regulators   of   a  
wide   range   of   cellular   processes   by   modulating   gene  
expressed  in  CtBP1  depleted  xenografts  grown  in  MeS  
mice  that  could  be  promising  biomarkers  or  therapeutic  
targets  (Table  1).  Numerous  miRNAs  from  this  list  were  
showing  that  CtBP1  regulates  multiple  miRNAs  in  breast  
cancer.  Moreover,  GO  analysis  of  miRNA  target  genes  
demonstrated  that  CtBP1  regulates  miRNAs  associated  to  
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Table  1:  List  of  differentially  expressed  miRNAs











MIMAT0027670 2.37 0.031 0.994
2.25 0.994
2.13 0.994
MIMAT0027393 2.05 0.006 0.994






MIMAT0027462 1.68 0.042 0.994
MIMAT0000449 1.66 0.032 0.994
1.65 0.006 0.994
1.61 0.017 0.994
MIMAT0027662 1.61 0.043 0.994
1.61 0.043 0.994
ENSG00000199370 ENSG00000199370 1.59 0.047 0.994
MIMAT0027627 1.57 0.034 0.994
MIMAT0003307 1.55 0.994
1.55 0.047 0.994
U101 U101 1.54 0.994
1.52 0.041 0.994





MI0001723 -­1.59 0.032 0.994
MI0006399 -­1.59 0.037 0.994
-­1.62 0.994
MI0003177 -­1.74 0.033 0.994
ENSG00000201042 ENSG00000201042 -­1.76 0.023 0.994
-­1.76 0.023 0.994
-­1.77 0.010 0.994
MIMAT0027497 -­2.12 0.007 0.994
-­2.48 0.994
MIMAT0000732 -­3.11 0.044 0.994
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Figure  5:  CtBP1  modulates  miRNAs  involved  in  metabolic  process,  proliferation  and  cell  communication  in  breast  
cancer  associated  to  MeS.  GeneChip  miRNA  4.0  Affymetrix  was  hybridized  to  total  RNA  from  xenografts  with  CtBP1  knockdown  or  
control  grown  in  mice  fed  with  HFD.  Predicted  target  genes  for  the  A.  CtBP1  downregulated  miRNAs;;  or  B.  CtBP1  upregulated  miRNAs  
were  determined  using  miRecords  data  base.  Pie  charts  show  GO  analysis  of  predicted  target  genes  using  GO  Panther.  Four  top  processes  
Oncotarget18807www.impactjournals.com/oncotarget
metabolism  and  processes  linked  to  cell  communication  
and  cell  cycle.  Thus,  future  studies  using  one  particular  
or  multiple  miRNAs  might  be  carried  out  to  understand  
the  mechanism  of  action  and  future  applications  of  these  
molecules.
Some  recent  studies  suggest   that  gastrointestinal  
tract   microbiota   modulates   cancer   development   in  
been  shown  to  alter  gut  microbial  communities  in  both  
cancer  progression   in  distal   tissues   such  as  mammary  
it  was  demonstrated  that  postmenopausal  women  with  
independent  low  diversity  of  their  gut  microbiota  [37].  
Hence,   gut   microbiota   analysis   from   HFD   fed   mice  
carcinogenesis.
molecular   link   that   associates   MeS   and   breast   cancer.  
CtBP1   expression   in   breast   cancer   tumors   might   be   a  
powerful  tool  for  diagnosis,  prognosis  and  therapy  in  a  
subgroup  of  breast  cancer  patients  with  MeS.
MATERIALS  AND  METHODS
Cell  culture,  plasmids  and  transfections
were  grown  in  DMEM  medium  (GIBCO)  supplemented  
with  10%  of   fetal  bovine   serum  (FBS)  and  antibiotics.  
DMEM  medium  (GIBCO)  supplemented  with  10%  of  calf  
serum  and  antibiotics.
were  generated  by   lentiviral   transduction  as  previously  
described  [13].  Stable  transfected  cells  were  selected  with  
Figure   6:  Model   proposed   for  CtBP1   in  breast   carcinogenesis   induced  by  MeS.  HFD   induces  NADH  activating  CtBP1  
expression  in  the  mammary  gland  which,  in  turn,  induce  prominent  epithelia  ducts  and  trigger  TEB  formation.  After  tumor  growth  initiates,  
high  CtBP1  expression  might  provide  a  worse  prognosis  to  the  patients  modulating  the  expression  of  genes  and  miRNAs  that  are  involved  
in  cell  proliferation,  progenitor  cells  phenotype,  EMT  and  mammary  development  in  breast  tumors.
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PolySciences  INC)  with  PEI:DNA  ratio  2:1.
pcDNA3   plasmid  was   from   Invitrogen.   pcDNA3  
CtBP1  plasmid  was  kindly  provided  by  Dr.  Richard  H.  
University  Portland).  pGIPZ  shRNA  Scramble  plasmid  
was  from  Open  Biosystems.  shRNA  CtBP1  plasmids  mix  
was  from  Santa  Cruz  Biotechnology  Inc.
Western  blot  (WB)
Cells  were  lysed  and  immunoblotted  as  previously  
Cruz  Biotechnology  Inc.).
RNA  isolation,  cDNA  synthesis  and  qPCR  (RT-­
qPCR)
RNA  was  isolated  using  Tri  Reagent  (Genbiotech,  
Buenos   Aires,   Argentina).   cDNA   was   synthesized  
described  [13]  using  Taq  polymerase  (Embiotec,  Buenos  
Aires,  Argentina)   in   a  Biorad  CFX   (Biorad).  Data  was  
shown  in  Supplemental  Table  1.
Cell  viability  and  cell  cycle  analysis
Promega)   according   to  manufacturer   instructions   [39].  
h  were  stained  with  propidium  iodide  (PI)  and  analyzed  by  
described  [40].
Orthotopic  xenograft  and  MeS  murine  models
Four  weeks  old   female  nu nu  mice   (N=24),  were  
housed   under   pathogen   free   conditions   following   the  
IBYME’s  animal  care  guidelines.  Mice  were  randomized  
into  2  dietary  groups  and  fed  ad  libitum  during  16  weeks  
described  [13].  For  HFD,  the  regular  chow  food  mouse  
(Fatty,   Buenos   Aires,   Argentina).   Body   weight   was  
monitored   once   a   week.   After   10   weeks   mice   were  
6).   Tumor  
volume  was  determined  three  times  a  week  and  calculated  
the  16th  week  and  tumor,  contralateral  breast,  liver,  kidney  
and  blood  samples  were  collected.  Mice  serum  glucose,  
cholesterol  and   triglycerides   levels  were  determined  as  
previously  described  [13].  Histological  analysis  and  IHC  
Mammosphere  formation  and  clonogenic  assays
Four  weeks  old   female  nu nu  mice   (N=24),  were  
housed   under   pathogen   free   conditions   following   the  
University  of  Buenos  Aires’s  animal  care  guidelines.  Mice  
were  randomized  into  2  dietary  groups  and  fed  during  16  
by  heart  puncture  and  serum  was  separated.  For  primary  
HFDS).  Then  104   cells  were   seeded   in   low  attachment  
mammosphere  number  and  diameter  were  determined  as  
previously  described  [41].
For   secondary   mammosphere   formation   assay,  
of  CDS  or  HFDS  for  144  h.  Primary  mammospheres  were  
second  mammosphere  assay  [41].
Clonogenic  assay  was  performed  as  previously  [42]  
with  3x103  cells  treated  with  CDS  or  HFDS  for  6  days.
Mammary  whole  mount
Mammary  whole  mount  was  performed  as  previously  
aluminum  carmine  red  solution.  Samples  were  dehydrated  
and   cleared   with   xylene.   Number   of   branches,   lateral  
miRNA  microarrays
GeneChip   miRNA   4.0   arrays   (Affymetrix)   were  
hybridized  with  RNA  from  shRNA  Scramble  and  shRNA  
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CtBP1  MeS  xenograft   tumors.  Data   normalization   and  
analysis   were   performed   using   Expression   Console™  
Software  1.3.1  and  Affymetrix®  Transcriptome  Analysis  
Console   (TAC)   Software.   Differentially   expressed  
regulated   genes.   Predicted   miRNAs   target   genes   from  
each   group   were   obtained   using   miRecords   which  
valid  targets  those  genes  that  were  predicted  by  at  least  3  
data  bases.  Duplicated  genes  between  both  groups  were  
eliminated.
Furthermore,  validated  target  genes  of  differentially  
expressed  miRNAs  were  determined  using  MiRTarBase  
Statistical  analysis
All  results  are  given  as  mean  and  standard  deviation  
(SD)   of   three   independent   experiments.   Student   t   tests  
in  vivo
ANOVA   followed   by   Bonferroni   test   were   performed.  
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